International Symposium organized by the Students of the Graduate School of Life Sciences

    Career Session

    The career session offers the great opportunity to gain insight in all the different career options that a graduated PhD student can follow. Interesting speakers from various scientific backgrounds will give a short introduction about their own career as well as their current working field and are open for further discussions. 


    PD Dr. med. Bodo Eing

    SYNLAB MVZ Leinfelden- Echterdingen  GmbH

    Work:  Dr. Bodo Eing finished his Medical studies at the Ruprecht-Karls-University of Heidelberg, Germany, with an MD degree on the role of carbohydrate compounds of the glycoprotein surface of Herpes Simples Virus Type1. Thereafter, he completed residencies in Internal Medicine and Medical Microbiology at the Institute of Medical Microbiology and Immunology of the Municipal Hospital of Karlsruhe, Germany, as a Specialist for Medical Microbiology and Epidemiology.

    Bodo Eing then entered a career in academia at the Westfälische Wilhelms-University of Münster, where he focussed on the establishment of an organ model for the intraneural transport of Herpes Simplex Viruses, based on a double chamber assembly with trigeminal ganglia from chicken embryos. Additional activities comprised basic research on Human Herpesvirus 6 and initiation of the Study Group on Transmissible Spongioform Encephaloapthies (TSE) of the University of Münster. Bodo Eing still teaches as a private lecturer at the University of Münster.

    After his career in academia Bodo Eing joined the SYNLAB trust as a Specialist for Medical Microbiology at the SYNLAB subsidiary lab site in Augsburg, Germany, soon taking over responsibility as Medical Director for this site. Later on he was appointed CEO for 7 SYNLAB  subsidiary companies in the South- West of Germany. Currently, Bodo Eing serves SYNLAB as CEO of the three largest lab sites in south West Germany, and as Medical Director for the SYNLAB lab site in Leinfelden- Echterdingen, Germany.


    Prof. Dr. Dominik Rüttinger

    Roche Innovation Center Munich, Pharma Research and Early Development (pRED)

    Work: Prof. Rüttinger completed residencies in Intensive Care and Surgical Oncology and is board certified in Surgery and Thoracic Surgery from the Ludwig-Maximilians-University of Munich (LMU), Germany. After fellowships within the Tumor Immunology Training Program at the Earle A. Chiles Research Institute, Providence Cancer Center, Oregon Health and Science University, Portland, USA and the Surgical Oncology Program at LMU, Prof. Rüttinger received his Ph.D. in Tumor Immunology at the University of Munich, where he still teaches and holds a faculty position.

    During his career in academia Prof. Rüttinger focused his translational research on cancer immunotherapy and served as principal investigator on multiple international Phase 1-3 clinical trials investigating active-specific immunotherapy and antibody-based approaches. He headed the Munich NSCLC Vaccine Study Group and served as an advisor for the Gene Therapy Advisory Board UK (GTAC) and the Dutch Ministry of Health, Welfare and Sports. Prof. Rüttinger is also co-chairman of the German Society of Immunotherapy and Targeted Therapy (DGFIT). He served as ad hoc reviewer/board member for several oncology journals and has published more than 80 original articles and chapters.

    In 2007, Prof. Rüttinger joined Micromet Inc. (now Amgen Research), where he lastly served as Head Clinical Development Solid Oncology. Prof. Rüttinger joined Roche/Genentech in 2011 and has led multiple early clinical stage immunotherapy programs. He now serves as the Global Head Early Clinical Development Oncology leading a team of ca. 90 physicians, imaging scientists, pathologist, biomarker and clinical scientists.


    Prof. Dr. Ismeni Walter

    Professor for environmental  journalism, University Ansbach, free journalist 

    Work: Prof. Dr. Ismeni Walter studied Biology in Munich, Boston, and Hamburg and received her PhD in marine biology, focusing on environmental toxicology, from the University of Hamburg. Since 1999 she is working freelance as a science- and environmental journalist for Arte, ARD and WDR in Cologne. Hereby she is being responsible for the School`s TV and German TV-Shows like Quarks & Co, W wie Wissen and Nano, just to name a few. From 2011 on she teaches in the departmental journalism course at Ansbach University of Applied Sciences. There she is responsible for the focus on energy and the environment and in her teaching and research she deals, among other things, with the communication of environmental topics.



    Daryl David, PhD

    Associate Editor of Cell and Developmental Biology at Nature Communications

    Work: Daryl joined Nature Communications in February 2018.  He obtained his PhD at the University of Toronto in the Collaborative Program in Developmental Biology, working on dynamic cytoskeletal networks and their regulation by the cell polarity machinery during Drosophila embryogenesis.  For his postdoctoral research at the Pasteur Institute, Daryl investigated secreted virulence factors of Listeria monocytogenes and their host cell targets. He currently handles manuscripts in cell biology including membranes and trafficking, cell division and cell cycle, cell motility and adhesion, mechanobiology, and nuclear cell biology.